Pablo
Pelegrin Vivancos
Catedraticos de Universidad
Hospital Morales Meseguer
Murcia, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Morales Meseguer (2)
2023
-
NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy
Cell Reports Medicine, Vol. 4, Núm. 12
2012
-
2-methoxyestradiol in the pathophysiology of endometriosis: Focus on angiogenesis and therapeutic potential
Reproductive Sciences, Vol. 19, Núm. 10, pp. 1018-1029